Stay updated with breaking news from Biologically Inspired Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novel delivery of established growth and neurotropic factors developed at Wyss Institute enables local, sustained release for greater efficacy.
Biologically inspired adhesive may improve prenatal surgery
Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
Novel delivery of established growth factors enables local, sustained release for greater efficacy...